Literature DB >> 31723491

In-situ Coronary Thrombosis in Antiphospholipid Syndrome: A Case Report.

Hira Pervez1, Sharan Rufus2, Prabhakaran Gopalakrishnan3.   

Abstract

Antiphospholipid antibody syndrome (APS) is a systemic autoimmune disorder characterized by arterial and venous thrombosis, often accompanied by elevated titers of anti-phospholipid antibodies. Cardiac involvement in APS is not uncommon. However, acute myocardial infarction (AMI) from in-situ thrombosis is a rare but important manifestation of APS. We present a rare case of AMI in a young female with APS secondary to in-situ coronary thrombosis.
Copyright © 2019, Pervez et al.

Entities:  

Keywords:  anti-phospholipid syndrome; aps; coronary arteries; coronary in-situ thrombus; coronary thrombosis in systemic diseases; thrombosis

Year:  2019        PMID： 31723491      PMCID： PMC6825431          DOI： 10.7759/cureus.5727

Source DB:  PubMed          Journal:  Cureus        ISSN： 2168-8184


  10 in total

Review 1.  Accelerated atherosclerosis in autoimmune rheumatic diseases.

Authors:  Yehuda Shoenfeld; Roberto Gerli; Andrea Doria; Eiji Matsuura; Marco Matucci Cerinic; Nicoletta Ronda; Luis J Jara; Mahmud Abu-Shakra; Pier Luigi Meroni; Yaniv Sherer
Journal:  Circulation       Date:  2005-11-22       Impact factor: 29.690

2.  International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).

Authors:  S Miyakis; M D Lockshin; T Atsumi; D W Branch; R L Brey; R Cervera; R H W M Derksen; P G DE Groot; T Koike; P L Meroni; G Reber; Y Shoenfeld; A Tincani; P G Vlachoyiannopoulos; S A Krilis
Journal:  J Thromb Haemost       Date:  2006-02       Impact factor: 5.824

3.  A rare presentation of primary antiphospholipid syndrome.

Authors:  Panduranga Prashanth; Mohammed Mukhaini; Abdulla Riyami
Journal:  Oman Med J       Date:  2009-10

4.  Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients.

Authors:  Ricard Cervera; Jean-Charles Piette; Josep Font; Munther A Khamashta; Yehuda Shoenfeld; María Teresa Camps; Soren Jacobsen; Gabriella Lakos; Angela Tincani; Irene Kontopoulou-Griva; Mauro Galeazzi; Pier Luigi Meroni; Ronald H W M Derksen; Philip G de Groot; Erika Gromnica-Ihle; Marta Baleva; Marta Mosca; Stefano Bombardieri; Frédéric Houssiau; Jean-Christophe Gris; Isabelle Quéré; Eric Hachulla; Carlos Vasconcelos; Beate Roch; Antonio Fernández-Nebro; Marie-Claire Boffa; Graham R V Hughes; Miguel Ingelmo
Journal:  Arthritis Rheum       Date:  2002-04

Review 5.  Antiphospholipid syndrome and the heart: a case series and literature review.

Authors:  Gentian Denas; Seema Padayattil Jose; Alessia Bracco; Giacomo Zoppellaro; Vittorio Pengo
Journal:  Autoimmun Rev       Date:  2014-11-12       Impact factor: 9.754

6.  Myocardial infarction in young patients without coronary atherosclerosis: assume primary antiphospholipid syndrome until proved otherwise.

Authors:  J O J Davies; B J Hunt
Journal:  Int J Clin Pract       Date:  2007-03       Impact factor: 2.503

7.  Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients.

Authors:  J L Vianna; M A Khamashta; J Ordi-Ros; J Font; R Cervera; A Lopez-Soto; C Tolosa; J Franz; A Selva; M Ingelmo
Journal:  Am J Med       Date:  1994-01       Impact factor: 4.965

Review 8.  Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome.

Authors:  M Hojnik; J George; L Ziporen; Y Shoenfeld
Journal:  Circulation       Date:  1996-04-15       Impact factor: 29.690

9.  A new technique to salvage myocardium following the failure of thrombus aspiration in acute myocardial infarction: a case report.

Authors:  Daoyuan Si; Guohui Liu; Yaliang Tong; Cheng Zhang; Yuquan He
Journal:  BMC Cardiovasc Disord       Date:  2018-12-10       Impact factor: 2.298

Review 10.  Cardiac Manifestations of Antiphospholipid Syndrome With Focus on Its Primary Form.

Authors:  Tamara Kolitz; Shachaf Shiber; Itzhak Sharabi; Asher Winder; Gisele Zandman-Goddard
Journal:  Front Immunol       Date:  2019-05-10       Impact factor: 7.561
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.